Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
|
|
Audience:
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from
ViiV Healthcare
Description:
The human immunodeficiency virus (HIV) is a lentivirus that causes
HIV infection and over time acquired immunodeficiency syndrome
(AIDS). AIDS is a condition in humans in which progressive failure
of the immune system allows life-threatening opportunistic
infections and cancers to thrive. HIV infects vital cells in the
human immune system such as helper T cells, macrophages, and
dendritic cells. HIV infection leads to low levels of CD4+ T cells
through a number of specific mechanisms. When CD4+ T cell numbers
decline below a critical level, cell-mediated immunity is lost, and
the body becomes progressively more susceptible to opportunistic
infections. The CDC estimates that 1,218,400 persons in the United
States aged 13 years and older are living with HIV infection.
Additionally, an estimated 15,815 people died from HIV and AIDS in
2021. Fortunately for patients with HIV, several new therapies have
become available over the past year, including long-acting
injectable therapies for both treatment and PrEP and options for
heavily treatment-experienced (HTE) patients. With so many new
options entering the treatment paradigm, it is critical that medical
directors, practicing physicians, nurses and other healthcare
professionals are updated on these emerging options and guidelines
and strategies for implementing them into the treatment paradigm and
individualizing therapy, which will ultimately improve clinical and
economic outcomes.
Upon completion of this
activity, participants will be able to:
-
Examine the clinical and economic
burden of HIV, including barriers to preexposure prophylaxis (PrEP)
uptake and persistence
-
Analyze optimal ART and PrEP
regimens based on patient- or drug-related factors, including
age, comorbidities, concomitant medications, potential for
ART-related toxicities, adherence, or patient preferences
-
Explore the role of long-acting
injectable therapy in HIV management and review which patients
would benefit from long-acting ART or PrEP
-
Evaluate therapies for heavily
treatment-experienced (HTE) adults with multidrug-resistant
HIV-1 infection
-
Discuss the disparities in HIV PrEP
related to race, gender, age, and other social determinants of
health
-
Assess the role of managed care
organizations in partnering with the health care team to reduce
barriers to ART or PrEP and improve access and persistence
|
Faculty: |
David A. Wohl, MD
Professor, Institute of Global Health and Infectious
Diseases
The University of North Carolina at Chapel Hill
Site Leader, UNC HIV Clinical Research Unit at Chapel
Hill |
|
Disclosure:
|
(Relevant Financial Relationships with Ineligible
Companies in the Last 24 Months):
Dr. Wohl has served as a consultant for Gilead, Janssen,
and ViiV Healthcare. He has received grant/research
support from Gilead and ViiV Healthcare. His
presentation has been reviewed for any bias. |
|
Planning Committee: |
Bill
Williams, MD has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jeremy Williams has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial
relationships with an ineligible company in the last 24
months to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity. |
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is supported by an educational grant from
ViiV Healthcare
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
professional.
Click Here To Continue |